Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Xenetic Biosciences, Inc. And the University of Virginia Have Initiated a Research Agreement to Advance Their Oncology Platform Based on DNase Technology
Thursday, January 18, 2024Xenetic Biosciences Inc has disclosed a strategic collaboration with the University of Virginia through the announcement of a Research Funding Agreement and a Material Transfer Agreement
Nurix Therapeutics Granted Fast Track Designation by the U.S. FDA for NX-5948 in the Treatment of Relapsed or Refractory CLL and SLL
Wednesday, January 17, 2024Nurix Therapeutics Inc has disclosed that the US Food and Drug Administration has granted Fast Track designation for NX a selective degrader of Brutons tyrosine kinase
Willow and Enterin Collaborate to Develop Sustainable Intermediates and Active Pharmaceutical Ingredients (APIs)
Wednesday, January 17, 2024Willow Biosciences Inc a leading biotechnology firm focused on advancing the industrial production of pure consistent and sustainable ingredients has revealed a collaborative effort with Enterin Inc
CARsgen's CT011 Secures NMPA Investigational New Drug Clearance for Stage Ⅲa Hepatocellular Carcinoma with High Recurrence Risk After Surgical Resection and GPC3 Positivity
Tuesday, January 16, 2024CARsgen Therapeutics Holdings Limited has recently disclosed that its autologous CAR Tcell product candidate CT which targets Glypican has secured Investigational New Drug clearance from the National Medical Products Administration
GenFleet Therapeutics' GFH009 Granted FDA Fast Track and Orphan Drug Designations for Lymphomas and Leukemia
Friday, January 12, 2024GenFleet Therapeutics a biotechnology company focused on developing advanced therapies in oncology and immunology recently announced that the US Food and Drug Administration has granted two additional designations
SyntheticGestalt and Enamine Forge Partnership to Develop AI-Driven Model for Streamlining Drug Discovery
Friday, January 12, 2024SyntheticGestalt and Enamine both prominent in AIdriven life sciences research and chemical building blocks have jointly initiated a project to develop AI models for generating biologically active compounds
HUTCHMED's Sovleplenib Receives NDA Approval in China for Primary Immune Thrombocytopenia Treatment with Priority Review Status
Thursday, January 11, 2024HUTCHMED Limited has made an announcement regarding the acceptance for review and the granting of priority review by the China National Medical Products Administration for the New Drug Application
Leqembi® Receives Approval for the Treatment of Alzheimer's Disease in China
Wednesday, January 10, 2024Eisai in collaboration with BioArctic AB announced today that Leqembi has received approval in China for the treatment of mild cognitive impairment due to Alzheimers disease and mild AD dementia China is the third country to grant marketing approval
OBI Pharma's Partner, Biosion, Announces FDA Approval of IND Application for Phase 1/2 Trial of OBI-992 (TROP2 ADC)
Tuesday, January 09, 2024Biosion Incs partner OBI Pharma has received clearance from the US Food and Drug Administration for an investigational new drug application related to OBI a novel antibody drug conjugate
Abbisko Therapeutics Has Been Granted Orphan Drug Designation by the European Medicines Agency (EMA) for Its CSF-1R Inhibitor Pimicotinib (ABSK021)
Tuesday, January 09, 2024Abbisko Therapeutics has recently announced that its experimental CSFR inhibitor pimicotinib has been granted orphan drug designation by the European Medicines Agency
